Tue, Feb 27, 2024 11:22 AM
Zenith Drugs stock lists at 39% premium to IPO price on NSE SME
A Flip by Riya Sharma
Palantir Technologies shares are rising in premarket trading Friday after the analytics software provider said it is shifting its listing to the Nasdaq from the NYSE. The company, a retail investor favorite, said it will transfer the listing of its Class A common shares to the Nasdaq Global Select Market, with trading set to start on Nov. 26, making it eligible for Nasdaq 100 inclusion.
Open Flip
Citadel Securities’ Durham Abric says the Federal Reserve’s interest-rate path probably will be uninterrupted by the incoming Trump administration’s protectionist posture. Former President Donald Trump, who imposed punitive tariffs on US imports in his first term, has made it clear he’ll do so again on taking office in January.
Open Flip
Donald Trump's appointment of vaccine skeptic Robert F Kennedy Jr as health secretary sparks concerns, causing pharma stocks to plummet, with GSK, AstraZeneca, and Sanofi shares dropping by as much as 4.4% due to Kennedy's anti-vax views and potential impact on vaccine development and public health policies.
Open Flip
